| INSPIRA | abequolixron | Oncology |
| INSPIRA | abequolixron zinc | Oncology |
| PHARMACYCLICS | abexinostat | Oncology |
| ASTRAZENECA | acalabrutinib | Oncology |
| ACERTA PHARMA | acalabrutinib | Oncology |
| GILEAD | acalisib | Oncology |
| AMGEN | acapatamab | Oncology |
| MODERNA | acavameran | Oncology |
| ACTINIUM | actinium (225ac) lintuzumab satetraxetan | Oncology |
| MIRATI | adagrasib | Oncology |
| ASTRAZENECA | adavosertib | Oncology |
| ADAPTIMMUNE | afamitresgene autoleucel | Oncology |
| ADAPTIMMUNE | afamitresgene autoleucel | Oncology |
| PFIZER | agatolimod | Oncology |
| SHIONOGI PHARMA | alicdamotide | Oncology |
| TAKEDA | alisertib | Oncology |
| GILEAD | alobresib | Oncology |
| KYMAB | alomfilimab | Oncology |
| ASCENTAGE PHARMA | alrizomadlin | Oncology |
| FIVE PRIME THERAPEUTICS | alsevalimab | Oncology |
| CHONG KUN DANG | alteminostat | Oncology |
| BRISTOL MYERS SQUIBB | alvespimycin | Oncology |
| BRISTOL MYERS SQUIBB | alvespimycin hydrochloride | Oncology |
| SANOFI | amcenestrant | Oncology |
| SANOFI | amcenestrant | Oncology |
| JANSSEN | amivantamab | Oncology |
| KYMAB | amlitelimab | Oncology |
| BRISTOL MYERS SQUIBB | amrubicin hydrochloride | Oncology |
| BRII BIOSCIENCES | amubarvimab | Oncology |
| GILEAD | andecaliximab | Oncology |
| JANSSEN | apalutamide | Oncology |
| BAYER | aprutumab | Oncology |
| BAYER | aprutumab ixadotin | Oncology |
| ISOFOL | arfolitixorin | Oncology |
| BIOSIGHT | aspacytarabine | Oncology |
| GSK | astuprotimut-r | Oncology |
| SHIONOGI PHARMA | asudemotide | Oncology |
| GENENTECH | atezolizumab | Oncology |
| EQRX | aumolertinib | Oncology |
| EQRX | aumolertinib mesylate | Oncology |
| GENENTECH | autogene cevumeran | Oncology |
| GENENTECH | autogene cevumeran | Oncology |
| BASILEA PHARMACEUTICA | avanbulin | Oncology |
| BLUEPRINT MEDICINES | avapritinib | Oncology |
| NEKTAR | avipendekin pegol | Oncology |
| BEYONDBIO | avotaciclib | Oncology |
| ADVAXIS | axalimogene filolisbac | Oncology |
| SYNDAX | axatilimab | Oncology |
| ABBVIE | azintuxizumab | Oncology |
| ABBVIE | azintuxizumab vedotin | Oncology |
| MERCK & CO. | baloramotide | Oncology |
| ISU ABXIS | barecetamab | Oncology |
| ARIVIVE | batiraxcept | Oncology |
| ARVINAS | bavdegalutamide | Oncology |
| GSK | belantamab | Oncology |
| GSK | belantamab mafodotin | Oncology |
| SPECTRUM PHARMACEUTICALS | belinostat | Oncology |
| GSK | belizatinib | Oncology |
| HANMI PHARMACEUTICALS | belvarafenib | Oncology |
| MERCK & CO. | belzutifan | Oncology |
| FIVE PRIME THERAPEUTICS | bemarituzumab | Oncology |
| BERGEN BIO | bemcentinib | Oncology |
| ATEA PHARMACEUTICALS | bemnifosbuvir | Oncology |
| ATEA PHARMACEUTICALS | bemnifosbuvir sulfate | Oncology |
| NEKTAR | bempegaldesleukin | Oncology |
| BioInvent International | bersanlimab | Oncology |
| VERTEX PHARMACEUTICALS | berzosertib | Oncology |
| AMGEN | bevacizumab beta | Oncology |
| ASTRAZENECA | bicalutamide | Oncology |
| PIQUR | bimiralisib | Oncology |
| Inovio | bizalimogene ralaplasmid | Oncology |
| MEDIMMUNE | blinatumomab | Oncology |
| AGENUS | botensilimab | Oncology |
| MEREO BIOPHARM | brontictuzumab | Oncology |
| ABBVIE | budigalimab | Oncology |
| FIVE PRIME THERAPEUTICS | cabiralizumab | Oncology |
| EXELIXIS | cabozantinib | Oncology |
| MERCK & CO. | cadalimogene ixalentivec | Oncology |
| ADC THERAPEUTICS | camidanlumab | Oncology |
| ADC THERAPEUTICS | camidanlumab tesirine | Oncology |
| ASTRAZENECA | camizestrant | Oncology |
| MONOPAR | camsirubicin | Oncology |
| TAKARA BIO | canerpaturev | Oncology |
| IMMUNOGEN | cantuzumab ravtansine | Oncology |
| ASTRAZENECA | capivasertib | Oncology |
| ADVAXIS | capolimogene apralisbac | Oncology |
| JOHNSON & JOHNSON | carlumab | Oncology |
| TRACON PHARMACEUTICALS | carotuximab | Oncology |
| Astex | cedazuridine | Oncology |
| ABBVIE | cedirogant | Oncology |
| ASTRAZENECA | ceralasertib | Oncology |
| ALEXION PHARMACEUTICALS | cerdulatinib | Oncology |
| Janssen | cetrelimab | Oncology |
| GENENTECH | cevostamab | Oncology |
| JANSSEN | ciltacabtagene autoleucel | Oncology |
| PIERIS PHARMACEUTICALS | cinrebafusp alfa | Oncology |
| LYCERA | cintirorgon | Oncology |
| SAMUMED | cirtuvivint | Oncology |
| GENENTECH | cobimetinib | Oncology |
| BAYER | copanlisib | Oncology |
| GENORBIO | coprelotamab | Oncology |
| CHECKPOINT THERAPEUTICS | cosibelimab | Oncology |
| GILEAD | dalutrafusp alfa | Oncology |
| CHINOOK THERAPEUTICS | damistimagene matitucel | Oncology |
| ASTRAZENECA | danvatirsen | Oncology |
| JANSSEN | daratumumab | Oncology |
| BAYER | darolutamide | Oncology |
| IDEAYA BIOSCIENCES | darovasertib | Oncology |
| DAIICHI-SANKYO | datopotamab | Oncology |
| DAIICHI-SANKYO | datopotamab deruxtecan | Oncology |
| CERULEAN | davamotecan pegadexamer | Oncology |
| REGENERON | davutamig | Oncology |
| ASTRAZENECA | defosbarasertib | Oncology |
| MEREO BIOPHARM | demcizumab | Oncology |
| NANOCARRIER | demplatin pegraglumer | Oncology |
| SEAGEN | denintuzumab mafodotin | Oncology |
| ABBVIE | depatuxizumab | Oncology |
| ABBVIE | depatuxizumab mafodotin | Oncology |
| ARQULE | derazantinib | Oncology |
| ARQULE | derazantinib hydrochloride | Oncology |
| RAFAEL PHARMACEUTICALS | devimistat | Oncology |
| APOTEX | docetaxel | Oncology |
| CANTEX PHARMACEUTICALS | dociparstat | Oncology |
| ARCUS | domvanalimab | Oncology |
| NOVARTIS | dovitinib | Oncology |
| NOVARTIS | dovitinib lactate | Oncology |
| GENENTECH | dulanermin | Oncology |
| GENENTECH | duligotuzumab | Oncology |
| JANSSEN | duvortuxizumab | Oncology |
| KURA | edaxeterkib | Oncology |
| MEREO BIOPHARM | efaprinermin alfa | Oncology |
| MEDIMMUNE | efgivanermin alfa | Oncology |
| Genexine | efineptakin alfa | Oncology |
| ABBVIE | eftozanermin alfa | Oncology |
| RADIUS HEALTH | elacestrant | Oncology |
| SYNTA PHARMACEUTICALS | elesclomol | Oncology |
| ABBVIE | elotuzumab | Oncology |
| ONCOTHERAPY SCIENCE | elpamotide | Oncology |
| ACTUATE THERAPEUTICS | elraglusib | Oncology |
| PFIZER | elranatamab | Oncology |
| PFIZER | elranatamab | Oncology |
| AMGEN | eluvixtamab | Oncology |
| CURIS | emavusertib | Oncology |
| CURIS | emavusertib hydrochloride | Oncology |
| AMGEN | emerfetamab | Oncology |
| AGIOS | enasidenib | Oncology |
| ABBOTT LABORATORIES | enavatuzumab | Oncology |
| GSK | encelimab | Oncology |
| ATHENEX | encequidar | Oncology |
| SEAGEN | enfortumab vedotin | Oncology |
| CHINOOK THERAPEUTICS | enistimagene setitucel | Oncology |
| XCOVERY | ensartinib | Oncology |
| NEOGENIX ONCOLOGY | ensituximab | Oncology |
| GILEAD | entospletinib | Oncology |
| IGNYTA | entrectinib | Oncology |
| PFIZER | enzalutamide | Oncology |
| SHIONOGI PHARMA | epertinib | Oncology |
| APREA | eprenetapopt | Oncology |
| SPECTRUM PHARMACEUTICALS | eramkafusp alfa | Oncology |
| MEDIMMUNE | etaracizumab | Oncology |
| AMGEN | etevritamab | Oncology |
| Onxeo | etidaligide | Oncology |
| MEREO BIOPHARM | etigilimab | Oncology |
| NEKTAR | etirinotecan pegol | Oncology |
| NEKTAR | etirinotecan pegol tetrahydrochloride | Oncology |
| NEKTAR | etirinotecan pegol tetratriflutate | Oncology |
| ARCUS | etrumadenant | Oncology |
| SYNDEVRX | evexomostat | Oncology |
| GILEAD | evixapodlin | Oncology |
| EMD SERONO | evobrutinib | Oncology |
| CRISPR | evoncabtagene pazurgedleucel | Oncology |
| SANOFI | fedratinib | Oncology |
| GSK | feladilimab | Oncology |
| STEMLINE THERAPEUTICS | felezonexor | Oncology |
| MORPHOSYS | felzartamab | Oncology |
| NIPPON KAYAKU | firtecan peglumer | Oncology |
| BLUEPRINT MEDICINES | fisogatinib | Oncology |
| SIEMENS | flortanidazole (18f) | Oncology |
| SIEMENS | flotegatide (18f) | Oncology |
| BLUE EARTH DIAGNOSTICS | flotufolastat (18f) | Oncology |
| MAST THERAPEUTICS | folitixorin | Oncology |
| MAST THERAPEUTICS | folitixorin calcium | Oncology |
| OXIGENE | fosbretabulin | Oncology |
| OXIGENE | fosbretabulin disodium | Oncology |
| OXIGENE | fosbretabulin tromethamine | Oncology |
| BIONOVUS LIFE SCIENCES | fosciclopirox | Oncology |
| NUCANA | fosgemcitabine palabenamide | Oncology |
| NUCANA | fosifloxuridine nafalbenamide | Oncology |
| TAIRX | foslinanib | Oncology |
| MEDIVIR | fostroxacitabine bralpamide | Oncology |
| BEIGENE | garivulimab | Oncology |
| GLYCOTOPE | gatipotuzumab | Oncology |
| SANOFI GENZYME | gatralimab | Oncology |
| PFIZER | gemtuzumab ozogamicin | Oncology |
| GENORBIO | geptanolimab | Oncology |
| ABBVIE | giloralimab | Oncology |
| ASTELLAS | gilteritinib | Oncology |
| UCB | ginisortamab | Oncology |
| MIRATI THERAPEUTICS | glesatinib | Oncology |
| AMGEN | gresonitamab | Oncology |
| ASTEX | guadecitabine | Oncology |
| PHARMACYCLICS | ibrutinib | Oncology |
| GILEAD | idelalisib | Oncology |
| ABBVIE | ilorasertib | Oncology |
| TAKEDA | imalumab | Oncology |
| ROCHE | imgatuzumab | Oncology |
| PHOSPLATIN THERAPEUTICS | imifoplatin | Oncology |
| TAKEDA | indusatumab | Oncology |
| TAKEDA | indusatumab vedotin | Oncology |
| LUNDBECK | ingenol disoxate | Oncology |
| BIPAR | iniparib | Oncology |
| BIOCANCELL THERAPEUTICS | inodiftagene vixteplasmid | Oncology |
| JOHNSON & JOHNSON | intetumumab | Oncology |
| ACTINIUM | iodine (131i) apamistamab | Oncology |
| MEREO BIOPHARM | ipafricept | Oncology |
| GENENTECH | ipatasertib | Oncology |
| SANOFI | isatuximab | Oncology |
| AGIOS | ivosidenib | Oncology |
| TAKEDA | ixazomib | Oncology |
| SEAGEN | ladiratuzumab | Oncology |
| SEAGEN | ladiratuzumab vedotin | Oncology |
| MERCK & CO. | lapretolimod | Oncology |
| IMMUNOGEN | laprituximab | Oncology |
| IMMUNOGEN | laprituximab emtansine | Oncology |
| DENDREON | lapuleucel-t | Oncology |
| VION | laromustine | Oncology |
| LOXO ONCOLOGY | larotrectinib | Oncology |
| ONCOTHERAPY SCIENCE | latromotide | Oncology |
| JANSSEN | lazertinib | Oncology |
| MOLOGEN | lefitolimod | Oncology |
| I-MAB | lemzoparlimab | Oncology |
| ISTARI ONCOLOGY | lerapolturev | Oncology |
| ISTARI ONCOLOGY | lerapolturev | Oncology |
| ADAPTIMMUNE | letetresgene autoleucel | Oncology |
| YM BIOSCIENCES | lexibulin | Oncology |
| IOVANCE BIOTHERAPEUTICS | lifileucel | Oncology |
| BEIGENE | lifirafenib | Oncology |
| ABBVIE | linifanib | Oncology |
| OSI PHARMACEUTICALS | linsitinib | Oncology |
| REGENERON | linvoseltamab | Oncology |
| CONSTELLATION | lirametostat | Oncology |
| ASCENTAGE PHARMA | lisaftoclax | Oncology |
| BASILEA PHARMACEUTICA | lisavanbulin | Oncology |
| JW THERAPEUTICS | lisocabtagene maraleucel | Oncology |
| ABBVIE | livmoniplimab | Oncology |
| SIRNAOMICS | lixadesiran | Oncology |
| TARVEDA | locnartecan | Oncology |
| ADC THERAPEUTICS | loncastuximab | Oncology |
| ADC THERAPEUTICS | loncastuximab tesirine | Oncology |
| MACROGENICS | lorigerlimab | Oncology |
| MACROGENICS | lorigerlimab | Oncology |
| JANSSEN | lorpucitinib | Oncology |
| APEIRON | lorukafusp alfa | Oncology |
| IMMUNOGEN | lorvotuzumab mertansine | Oncology |
| NOVARTIS | lucatumumab | Oncology |
| GILEAD | magrolimab | Oncology |
| Inovio | mavilimogene ralaplasmid | Oncology |
| X4 | mavorixafor | Oncology |
| ONCOPEPTIDES | melphalan flufenamide | Oncology |
| SYROS | mevociclib | Oncology |
| DAIICHI-SANKYO | milademetan | Oncology |
| ADC THERAPEUTICS | mipasetamab | Oncology |
| ADC THERAPEUTICS | mipasetamab uzoptirine | Oncology |
| TAKARA BIO | mipetresgene autoleucel | Oncology |
| DEKK-TREK | mipicoledine | Oncology |
| INSPYR Therapeutics | mipsagargin | Oncology |
| ARQULE | miransertib | Oncology |
| IMMUNOGEN | mirvetuximab soravtansine | Oncology |
| ABBVIE | mirzotamab | Oncology |
| ABBVIE | mirzotamab clezutoclax | Oncology |
| JANSSEN | mitazalimab | Oncology |
| TAKEDA | mivavotinib | Oncology |
| TAKEDA | mobocertinib | Oncology |
| MIRATI THERAPEUTICS | mocetinostat | Oncology |
| MIRATI THERAPEUTICS | mocetinostat dihydrobromide | Oncology |
| GSK | molibresib | Oncology |
| EnzyChem | mosedipimod | Oncology |
| GENENTECH | mosunetuzumab | Oncology |
| CRISPR | motacabtagene lurevgedleucel | Oncology |
| BIOLINE RX | motixafortide | Oncology |
| MEDIMMUNE | moxetumomab pasudotox | Oncology |
| AMGEN | murizatoclax | Oncology |
| GAMAMABS | murlentamab | Oncology |
| J-PHARMA | nanvuranlat | Oncology |
| IMMUNOGEN | naratuximab emtansine | Oncology |
| MEREO BIOPHARM | navicixizumab | Oncology |
| ABBVIE | navitoclax | Oncology |
| KARTOS | navtemadlin | Oncology |
| ARQULE | nemtabrutinib | Oncology |
| ALKERMES | nemvaleukin alfa | Oncology |
| TARVEDA | nendratereotide uzatansine | Oncology |
| TARVEDA | nendratereotide | Oncology |
| AUTOLUS | obecabtagene autoleucel | Oncology |
| BEIGENE | ociperlimab | Oncology |
| CHECKPOINT THERAPEUTICS | olafertinib | Oncology |
| ADAPTIMMUNE | olitresgene autoleucel | Oncology |
| HANMI PHARMACEUTICALS | olmutinib | Oncology |
| ASCENTAGE PHARMA | olverembatinib | Oncology |
| TEVA PHARMACEUTICALS INDUSTRIES | omacetaxine mepesuccinate | Oncology |
| GSK | omipalisib | Oncology |
| JANSSEN | onametostat | Oncology |
| BRISTOL MYERS SQUIBB | onatasertib | Oncology |
| BRISTOL MYERS SQUIBB | onatasertib | Oncology |
| Janssen | onvatilimab | Oncology |
| TIBURIO | onzigolide | Oncology |
| JANSSEN | opolimogene capmilisbac | Oncology |
| AMGEN | oprozomib | Oncology |
| TAKEDA | orteronel | Oncology |
| BRISTOL MYERS SQUIBB | orvacabtagene autoleucel | Oncology |
| AMGEN | pacanalotamab | Oncology |
| GERON | paclitaxel trevatide | Oncology |
| CYTOMX THERAPEUTICS | pacmilimab | Oncology |
| BEIGENE | pamiparib | Oncology |
| DAIICHI-SANKYO | patritumab | Oncology |
| AMGEN | pavurutamab | Oncology |
| JAZZ PHARMACEUTICALS | pegcrisantaspase | Oncology |
| AVELAS BIOSCIENCES | pegloprastide | Oncology |
| HALOZYME THERAPEUTICS | pegvorhyaluronidase alfa | Oncology |
| CONSTELLATION | pelabresib | Oncology |
| ASCENTAGE PHARMA | pelcitoclax | Oncology |
| MERCK & CO. | pembrolizumab | Oncology |
| Incyte | pemigatinib | Oncology |
| JANSSEN | pemlimogene merolisbac | Oncology |
| GSK | pemrametostat | Oncology |
| SILLAJEN | pexastimogene devacirepvec | Oncology |
| DAIICHI-SANKYO | pexidartinib | Oncology |
| PDS BIOTECHNOLOGY | pexipepimut-s | Oncology |
| SANOFI | pilaralisib | Oncology |
| JOUNCE | pimivalimab | Oncology |
| GENENTECH | pinatuzumab vedotin | Oncology |
| EPIZYME | pinometostat | Oncology |
| SIRNAOMICS | pixofisiran | Oncology |
| GENENTECH | polatuzumab vedotin | Oncology |
| BRISTOL MYERS SQUIBB | pomalidomide | Oncology |
| ARIAD | ponatinib | Oncology |
| ARIAD | ponatinib hydrochloride | Oncology |
| PFIZER | ponsegromab | Oncology |
| HANMI PHARMACEUTICALS | poseltinib | Oncology |
| ONCOTHERAPY SCIENCE | pradimotide | Oncology |
| BLUEPRINT MEDICINES | pralsetinib | Oncology |
| CYTOMX THERAPEUTICS | praluzatamab | Oncology |
| CYTOMX THERAPEUTICS | praluzatamab ravtansine | Oncology |
| BIO-PATH HOLDINGS | prexigebersen | Oncology |
| ARCUS | quemliclustat | Oncology |
| JOHNSON & JOHNSON | quisinostat | Oncology |
| BAYER | radretumab | Oncology |
| BAYER | refametinib | Oncology |
| JW PHARMACEUTICAL | relmacabtagene autoleucel | Oncology |
| 4SC | resminostat | Oncology |
| ABBVIE | revdofilimab | Oncology |
| BETA PHARMA | rezivertinib | Oncology |
| ACETYLON | ricolinostat | Oncology |
| BELLICUM PHARMACEUTICALS | rimiducid | Oncology |
| LSK BIOPHARMA | rivoceranib | Oncology |
| ABBVIE | rizankizumab | Oncology |
| CLOVIS ONCOLOGY | rociletinib | Oncology |
| ABBVIE | rolinsatamab | Oncology |
| ABBVIE | rolinsatamab talirine | Oncology |
| BAYER | roniciclib | Oncology |
| SYNTA PHARMACEUTICALS | rosabulin | Oncology |
| MEREO BIOPHARM | rosmantuzumab | Oncology |
| TELIX PHARMACEUTICALS | rosopatamab | Oncology |
| TELIX PHARMACEUTICALS | rosopatamab tetraxetan | Oncology |
| ABBVIE | rovalpituzumab | Oncology |
| ABBVIE | rovalpituzumab tesirine | Oncology |
| GALERA THERAPEUTICS | rucosopasem manganese | Oncology |
| GENENTECH | runimotamab | Oncology |
| LYTIX BIOPHARMA | ruxotemitide | Oncology |
| ABBVIE | samrotamab | Oncology |
| ABBVIE | samrotamab vedotin | Oncology |
| TAKEDA | sapanisertib | Oncology |
| IPSEN BIOPHARM LTD | satoreotide tetraxetan | Oncology |
| OCTREOPHARM | satoreotide trizoxetan | Oncology |
| ASTRAZENECA | savolitinib | Oncology |
| Salarius | seclidemstat | Oncology |
| KARYOPHARM | selinexor | Oncology |
| LOXO ONCOLOGY | selitrectinib | Oncology |
| LOXO ONCOLOGY | selpercatinib | Oncology |
| JANSSEN | seltorexant | Oncology |
| ASTRAZENECA | selumetinib | Oncology |
| ASTRAZENECA | selumetinib sulfate | Oncology |
| TAKEDA | serabelisib | Oncology |
| ABBVIE | serclutamab | Oncology |
| ABBVIE | serclutamab talirine | Oncology |
| JOHNSON & JOHNSON | serdemetan | Oncology |
| SANOFI | seribantumab | Oncology |
| INNOCRIN PHARMACEUTICALS | seviteronel | Oncology |
| TAKEDA | siltocabnagene loxiveleucel | Oncology |
| JOHNSON & JOHNSON | siltuximab | Oncology |
| GILEAD | simtuzumab | Oncology |
| TAKEDA | simurosertib | Oncology |
| DENDREON | sipuleucel-t | Oncology |
| MIRATI THERAPEUTICS | sitravatinib | Oncology |
| SEAGEN | sonolisib | Oncology |
| BAYER | sorafenib | Oncology |
| AMGEN | sotorasib | Oncology |
| AMGEN | sovilnesib | Oncology |
| THERATECHNOLOGIES | sudocetaxel zendusortide | Oncology |
| AILERON THERAPEUTICS | sulanemadlin | Oncology |
| LEAP THERAPEUTICS | surexatamab | Oncology |
| BEIGENE | surzebiclimab | Oncology |
| ONCOTHERAPYSCIENCE | tabituximab | Oncology |
| ONCOTHERAPYSCIENCE | tabituximab barzuxetan | Oncology |
| MORPHOSYS | tafasitamab | Oncology |
| JANSSEN | talacotuzumab | Oncology |
| PFIZER | talazoparib | Oncology |
| ANHEART THERAPEUTICS | taletrectinib | Oncology |
| ANHEART THERAPEUTICS | taletrectinib adipate | Oncology |
| JOHNSON & JOHNSON | talmapimod | Oncology |
| JANSSEN | talquetamab | Oncology |
| ABBVIE | tamrintamab | Oncology |
| ABBVIE | tamrintamab pamozirineab | Oncology |
| BRISTOL MYERS SQUIBB | tanespimycin | Oncology |
| AMGEN | tapotoclax | Oncology |
| MEREO BIOPHARM | tarextumab | Oncology |
| AMGEN | tarlatamab | Oncology |
| THRESHOLD PHARMACEUTICALS | tarloxotinib bromide | Oncology |
| DNATRIX, Inc. | tasadenoturev | Oncology |
| GENENTECH | taselisib | Oncology |
| OncoSec | tavokinogene telseplasmid | Oncology |
| EPIZYME | tazemetostat | Oncology |
| TAKARA BIO | tebrocabtagene autoleucel | Oncology |
| JANSSEN | teclistamab | Oncology |
| BetaCat | tegavivint | Oncology |
| CALITHERA | telaglenastat | Oncology |
| GLENMARK PHARMACEUTICALS | telazorlimab | Oncology |
| ABBVIE | telisotuzumab | Oncology |
| ABBVIE | telisotuzumab vedotin | Oncology |
| ASTRAZENECA | telratolimod | Oncology |
| ERIMOS PHARMACEUTICALS | terameprocol | Oncology |
| AURINIA | terameprocol | Oncology |
| AFFIBODY | tezatabep matraxetan | Oncology |
| GILEAD | tilpisertib | Oncology |
| IDERA PHARMACEUTICALS | tilsotolimod | Oncology |
| BERGEN BIO | tilvestamab | Oncology |
| GLYCOTOPE | timigutuzumab | Oncology |
| PFIZER | tinlorafenib | Oncology |
| MUNDIPHARMA | tinostamustine | Oncology |
| GILEAD | tirabrutinib | Oncology |
| GENENTECH | tiragolumab | Oncology |
| ATHENEX | tirbanibulin | Oncology |
| GENEXINE | tirvalimogene teraplasmid | Oncology |
| NOVARTIS | tisagenlecleucel | Oncology |
| BEIGENE | tislelizumab | Oncology |
| DAIICHI-SANKYO | tivantinib | Oncology |
| Effector | tomivosertib | Oncology |
| GLYCOTOPE | tomuzotuximab | Oncology |
| BLAZE BIOSCIENCE | tozuleristide | Oncology |
| AMGEN | trebananib | Oncology |
| SHIONOGI PHARMA | trempamotide | Oncology |
| SEAGEN | tucatinib | Oncology |
| BLACK DIAMOND | tuxobertinib | Oncology |
| REGENERON PHARMACEUTICALS | ubamatamab | Oncology |
| I-MAB | uliledlimab | Oncology |
| BIOMED VALLEY | ulixertinib | Oncology |
| GSK | uprosertib | Oncology |
| SURFACE ONCOLOGY | urabrelimab | Oncology |
| BRISTOL MYERS SQUIBB | vadacabtagene leraleucel | Oncology |
| BRISTOL MYERS SQUIBB | vadacabtagene leraleucel | Oncology |
| SEAGEN | vadastuximab | Oncology |
| SEAGEN | vadastuximab talirine | Oncology |
| CHONG KUN DANG | valecobulin | Oncology |
| MEREO BIOPHARM | vantictumab | Oncology |
| SUNESIS PHARMACEUTICALS | vecabrutinib | Oncology |
| INTREXON | veledimex | Oncology |
| ABBVIE | veliparib | Oncology |
| ABBVIE | venetoclax | Oncology |
| AMGEN | vepsitamab | Oncology |
| MYRIAD | verubulin | Oncology |
| GILEAD | vesatolimod | Oncology |
| ARQULE | vevorisertib | Oncology |
| CELLID | vibapapogene autoleucel | Oncology |
| DECIPHERA PHARMACEUTICALS | vimseltinib | Oncology |
| AMPHIVENA | vixtimotamab | Oncology |
| SPARC | vodobatinib | Oncology |
| Jounce | vopratelimab | Oncology |
| AGIOS | vorasidenib | Oncology |
| AGIOS | vorasidenib citrate | Oncology |
| TYROGENEX | vorolanib | Oncology |
| SEAGEN | vorsetuzumab mafodotin | Oncology |
| MEI PHARMA | voruciclib | Oncology |
| SUNESIS PHARMACEUTICALS | vosaroxin | Oncology |
| RADIUS HEALTH | vosilasarm | Oncology |
| JANSSEN | voxalatamab | Oncology |
| SANOFI | voxtalisib | Oncology |
| IPSEN BIOPHARM LTD | zalsenertant tetraxetan | Oncology |
| MILTENYI | zamtocabtagene autoleucel | Oncology |
| MEI PHARMA | zandelisib | Oncology |
| ZYMEWORKS | zanidatamab | Oncology |
| ZYMEWORKS | zanidatamab zovodotin | Oncology |
| BEIGENE | zanubrutinib | Oncology |
| GSK | zastumotide | Oncology |
| MARKER THERAPEUTICS | zedenoleucel | Oncology |
| MARKER THERAPEUTICS | zedenoleucel | Oncology |
| AMGEN | zeluvalimab | Oncology |
| MERUS | zenocutuzumab | Oncology |
| BOSTON PHARMACEUTICALS | zeteletinib | Oncology |
| BOSTON PHARMACEUTICALS | zeteletinib adipate | Oncology |
| KURA ONCOLOGY | ziftomenib | Oncology |
| VELOSBIO | zilovertamab | Oncology |
| VELOSBIO | zilovertamab vedotin | Oncology |
| ARCUS | zimberelimab | Oncology |
| ASTELLAS | zolbetuximab | Oncology |
| EFFECTOR | zotatifin | Oncology |
